Source avec lien : Healthcare Purchasing News, , 10/10/2019.
Les CDC ont publié de nouvelles directives en juillet sur l’utilisation d’équipement de protection individuelle (masques, blouses) par les fournisseurs de soins de santé pour protéger les patients dans ces établissements contre l’acquisition et la propagation de germes résistants aux antibiotiques. Pour vérifier l’efficacité de ces nouvelles recommandations, Mary-Claire Roghmann, MD, MS, professeure d’épidémiologie et de santé publique à la faculté de médecine de l’Université du Maryland (UMSOM) et ses collègues mèneront un essai qui débute en octobre et qui implique quatre foyers de soins communautaires dans le Maryland.
The Centers for Disease Control and Prevention estimates that more than two million people are infected with antibiotic-resistant organisms, resulting in approximately 23,000 deaths annually. Many of these infections spread in nursing homes and long-term rehabilitation facilities, and the CDC issued new guidance in July on the use of personal protective equipment (masks, gowns) by healthcare providers to protect patients in these facilities from acquiring and spreading antibiotic-resistant germs to others. The guidance recommends that workers be required to don a gown and gloves during high-contact activities… To test the effectiveness of these new recommendations, Mary-Claire Roghmann, MD, MS, Professor of Epidemiology and Public Health at the University of Maryland School of Medicine (UMSOM) and her colleagues received a $1.1 million award from the CDC to conduct a trial that starts in October and involves four community-based nursing homes in Maryland.